Traders Recap: Apple Inc. (NASDAQ:AAPL), Valeant Pharmaceuticals Intl Inc (NYSE:VRX), YY Inc (ADR)(NASDAQ:YY)

On Tuesday, Shares of Apple Inc. (NASDAQ:AAPL), added 1.32% and closed at $107.11 in the last trading session. The last trading range of the stock ranges between $104.08 and $107.81. Apple® recently declared the release of a new hardbound book chronicling 20 years of Apple’s design, expressed through 450 photographs of past and current Apple products. Designed by Apple in California, which covers products from 1998’s iMac® to 2015’s Apple Pencil®, also documents the materials and techniques used by Apple’s design team over two decades of innovation.

The book is dedicated to the memory of Steve Jobs.

“The idea of genuinely trying to make something great for humanity was Steve’s motivation from the starting, and it remains both our ideal and our aim as Apple looks to the future,” said Jony Ive, Apple’s chief design officer. “This archive is intended to be a gentle gathering of many of the products the team has designed over the years. We hope it brings some understanding to how and why they exist, while serving as a resource for students of all design disciplines.”

Valeant Pharmaceuticals Intl Inc (NYSE:VRX), jumped 3.82% and closed at $18.22 in the last trading session. The last trading range of the stock ranges between $16.72 and $18.57. The company’s Market capitalization is $6.06 Billion with the total Outstanding Shares of 341.19 million. Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Xifaxan for the treatment of irritable bowel syndrome with diarrhea; Wellbutrin XL for major depressive disorder in adults; Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Clindagel, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Glumetza to improve glycemic control in adults with type 2 diabetes mellitus; PROVENGE for the treatment of prostate cancer; and Jublia for onychomycosis of the toenails. It also provides Nitropress for the immediate reduction of blood pressure of patients in hypertensive crises; Isuprel for heart related treatments; Xenazine for chorea; Uceris to get ulcerative colitis under control; Lotemax gel for post-operative inflammation and pain; Arestin, a subgingival sustained-release antibiotic; PreserVision, an antioxidant eye vitamin and mineral supplement; CeraVe to rebuild and repair the skin barrier; Biotrue for healthy contact lens wear; and ReNu Multiplus to lubricate and rewet soft contact lenses. In addition, the company offers Ocuvite, a lutein eye vitamin and mineral supplement; Boston, a cleansing solution for gas permeable contact lenses; Artelac to treat dry eyes; various ophthalmic surgical products; SofLens daily disposable contact lenses; Biotrue ONEday lens; Bausch + Lomb Ultra, a contact lens PureVision, a contact lens; and medical device systems for aesthetic applications.

YY Inc (ADR)(NASDAQ:YY), dropped -0.14% and closed at $43.88 in the last trading session. The last trading range of the stock ranges between $43.31 and $45.27. During the 52-week trading session the minimum price at which share price traded, registered at $31.07 and reached to max level of $65.53. YY Inc. (YY) (“YY” or the “Company”), a live streaming platform, recently declared that it plans to release its third quarter 2016 financial results on Monday, November 21, 2016 before market open. The Company will hold a conference call on Monday, November 21, 2016 at 8:00 am Eastern Time or 9:00 pm Beijing Time to discuss the financial results.

Leave a Reply

Your email address will not be published. Required fields are marked *